UNSPSC 51101924: Bulaquine

This classification denotes an antimalarial agent with the molecular formula C21H27N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TSQ6U39Q3G, chemically known as 2(3h)-furanone, dihydro-3-(1-((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)ethylidene)- but generally known as bulaquine, which bears US NIH Compound Identifier 3036820. European Medicines Agency schedules Bulaquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00894MIG. The term BULAQUINE is an International Non-Proprietary Name.

Most nations schedule bulaquine under HS 29349990 and SITC 51579. As of Q4 2014, BULAQUINE remains the US FDA Preferred Term for this commodity. Bulaquine bears US NLM identifiers UMLS ID C0082079 and NCI Concept Code C75997. SMILES: O1CC/C(=C(\NCCCC(NC2C3NCCCC3CC(OC)C2)C)C)C1=O.

UNSPSC 51101924 Bulaquine, a Commodity code, encompasses pharmaceutical products and medical supplies that state and local governments procure for health, emergency response, and community health initiatives. Recent solicitations show state and local buyers acquiring naloxone and drug deactivation systems for community health programs, medical and first aid supplies for emergency response, generic pharmaceuticals and over-the-counter products for multi-jurisdictional distribution, and direct-to-manufacturer prescription programs to manage pharmacy benefit costs. The issuing bodies span county health departments, city fire and rescue services, state health and human services commissions, and cooperative purchasing alliances that aggregate demand across multiple state and local jurisdictions. Seminole County, Florida; the City of Tampa; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) have posted recent opportunities under or related to this code, indicating activity at the county, municipal, state, and multi-state cooperative levels.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County posted IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023. The City of Tampa issued ITB 26P00145 in March 2026 for medical and first aid supplies (169 line items) for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a response deadline of March 13, 2026; this opportunity is sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Texas Health and Human Services Commission released RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs with no formal award timeline. MMCAP, administered by Minnesota's Department of Administration, posted RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local governments with a response deadline of March 26, 2026 and contract effectiveness of July 1, 2026. The geographic concentration in Florida, Texas, and Minnesota reflects where recent solicitation activity has clustered, though cooperative purchasing vehicles expand reach across multiple states.